Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemiaRossana Maffei(University of Modena and Reggio Emilia), Roberto Marasca(University of Modena and Reggio Emilia)BloodApril 10, 201010.1182/blood-2009-11-252494Cited by 56SaveCiteExport RISWatch citationsRelated PapersIbrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia|Oncotarget|2016|103